Please login to the form below

Not currently logged in
Email:
Password:

ribociclib

This page shows the latest ribociclib news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s Ibrance misses the mark in early breast cancer

Pfizer’s Ibrance misses the mark in early breast cancer

Although Pfizer’s drug is the leader in this indication, it is facing increasing competition from the likes of Novartis’ Kisqali (ribociclib) and others for a share in the market.

Latest news

More from news
Approximately 4 fully matching, plus 33 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics